NCT00029328View on ClinicalTrials.gov

Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

September 30, 2003

Conditions
Respiratory Distress Syndrome, AdultBronchiolitis ObliteransPneumonia
Interventions
DRUG

etanercept

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

FDA Office of Orphan Products Development

FED

NCT00029328 - Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation | Biotech Hunter | Biotech Hunter